Malaria vaccine raises hopes after ‘positive results’

Durban – Results from a phase III clinical trial indicate that a malaria vaccine candidate reduces by half infections of malaria among children tested in Africa after an 18-month follow-up, signifying a major development in the fight against the killer disease. Researchers say the most clinically advanced malaria vaccine, RTS,S, created in 1987 by scientists working for GlaxoSmithKline (GSK), could be ready […]